Skip to main content
Figure 4 | Translational Neurodegeneration

Figure 4

From: Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease

Figure 4

Effect of 17-AAG on NFT area in JNPL3 mice. Area of AT8 immunopositivity in the medulla of JNPL3 mice treated with 17-AAG. Boxes represent 25th and 75th percentiles; medians are the lines across the boxes; whisker caps represent 5th and 95th percentiles; and open circles are outliers. Doses of 17-AAG are shown as 0 mg/kg, 5 mg/kg, or 25 mg/kg. Top: Males. Bottom: Females.

Back to article page